The COVID-19 pandemic disrupted the daily lives of many. However, with working vaccines available around the world, we have entered a new stage in the fight against this devastating disease: gathering in-depth information about the vaccine immune response.
To continue to support the scientific community in their quest to understand and find answers to COVID-19 itself and the vaccine immune response, access to anti-SARS-CoV-2 T cells, samples from convalescent donors, and vaccinated donor plasma, serum, and PBMC are available.
Cryopreserved COVID-19 Vaccinated Samples (Time Series)
The cryopreserved COVID-19 vaccinated samples (time series) can play an essential role in advancing our understanding of the immune response to COVID-19 vaccines. The COVID-19 vaccinated samples time series will provide scientists with matched sets of cellular products from individual healthy donors with no prior COVID-19 infection. The COVID-19 vaccinated samples (time series) are collected at the following time points:
- prior to COVID-19 vaccination
- 10-30 days after the first vaccine administration
- 10-30 days after the second vaccine administration (when applicable)
Donors include those who have been administered a COVID-19 vaccine from Pfizer, Moderna, or Johnson & Johnson.
Donor matched samples available include plasma, serum, and PBMCs.
The COVID-19 vaccinated series of products are a unique research tool that can promote understanding of the immune response to vaccination within the body including changes in immune activity over time, as well as examine vaccine efficacy among different donors and vaccine potency against different viral variants.
Visit our COVID-19 Research Tools and Products resource page to learn more about how we can support your COVID-19 related research.
Looking for COVID-19 products? Check out our complete inventory.